GENE ONLINE|News &
Opinion
Blog

Central Nervous System
First Oral SMA Drug by Roche Now Available to Newborns
2022-06-01
New Study Reveals Hope for Recovery of Patients with Spinal Cord Injury
2022-05-27
Emerging NY Biotech Furthers Sanofi’s CNS Therapeutics
2022-04-22
Biogen and Sage Therapeutics Ink Deal for Treating Depression
2020-11-29
Newly Discovered Immune Cells can Help Fight CNS Damage
2020-11-01
Spotlight: New Gene Therapies on the Horizon for the Treatment of Neurogenetic Diseases
2020-08-03
A Secondary Route of Viral Entry Could Explain Enhanced Pathogenicity of COVID-19
2020-06-14
A Review of Neurological Symptoms in COVID-19 Patients
2020-05-18
Novartis Announces Mayzent Data that Shows Extended Benefit in Secondary Progressive MS
2020-04-21
LATEST
Biogen’s Tofersen May Show Clinical Benefit in ALS Patients with Rare SOD1 Mutations
2023-03-21
Comparing ESG Regulations in the U.S., the U.K., and the EU
2023-03-21
See-Mode Technologies Secures Regulatory Approvals for its AI-powered Software that Automatically Analyses and Reports Breast & Thyroid Ultrasound Scans in Australia and New Zealand
2023-03-21
OncoC4 Bags $200 Million In CTLA-4 Antibody Pact With BioNTech
2023-03-21
HHS Issues Initial Guidance on Negotiation Program as Government’s Latest Move to Reduce Drug Prices
2023-03-21
First-Ever Insect Brain Neuron Map Completed
2023-03-21
AbbVie Unveils Latest Data For Skyrizi In Difficult-To-Treat Psoriasis
2023-03-20
Scroll to Top